casein kinase IIα′ Activators

The first group of casein kinase IIα (CK2α) activators includes TBB, Quercetin, Apigenin, Ellagic Acid, Emodin, and Resveratrol. These compounds inhibit CK2α by binding to its ATP-binding site. This action results in a reduction of its kinase activity. Notably, this inhibitory action can indirectly enhance CK2α activity through a feedback mechanism. The body recognizes that CK2α activity is compromised due to the presence of these inhibitors and responds by upregulating the enzyme's activity to compensate. This group of compounds, therefore, indirectly enhances CK2α activity by triggering this compensatory response.

The second group of CK2α activators includes Silibinin, Genistein, EGCG, Curcumin, Fisetin, and Baicalein. Similar to the first group, these compounds inhibit CK2α by competing with ATP to bind to the ATP-binding site of the enzyme. The inhibitory action of these compounds can lead to an upregulation of CK2α activity as a response mechanism. When the body senses that CK2α activity is reduced due to the presence of these inhibitors, it responds by increasing the enzyme's activity. Thus, these compounds indirectly enhance CK2α activity by initiating this compensatory response.